ARCHIVES

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

Brawley: CMS Got it Right in Lung Cancer Screening Decision

November 14, 2014

FDA Softening Its Stance On CME Guidelines; New Version To Be More In Line with ACCME

April 3, 1992

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

DCIS With Higher Density May Increase Risk For Disease

October 29, 2010